Can early clinical parameters predict post-traumatic pituitary dysfunction in severe traumatic brain injury?

Nemes, O. and Kovács, N. and Szujo, Sz. and Bódis, B. and Bajnok, L. and Büki, A. and Dóczi, T. and Czeiter, Endre and Mezősi, E. (2016) Can early clinical parameters predict post-traumatic pituitary dysfunction in severe traumatic brain injury? Acta neurochirurgica, 158 (12). pp. 2347-2353. ISSN 0942-0940

Text Nemes 2016.pdf Restricted to Repository staff only Download (285kB)

Abstract

BACKGROUND Post-traumatic hypopituitarism is a major complication after severe head trauma. The aim of our study was to evaluate the possible role of early clinical parameters in the development of endocrine deficits. METHODS Data on endocrine function, on-admission clinical-, laboratory-, and ICU-monitored parameters were available in 63 patients of the surviving 86 severe head injury patients (post-resuscitation GCS under 8) treated at one neurosurgical center during a 10-year period. RESULTS Hypopituitarism was diagnosed in 68.3 % of the patients. The most frequently affected pituitary axis was the growth hormone (GH): GH deficiency or insufficiency was present in 50.8 %. Central hypogonadism affected 23.8 % of male patients; hypothyroidism and secondary adrenal failure were found in 22.2 and 9.5 % of the investigated population, respectively. Early onset (within 1 year of brain injury) hypopituitarism was found in 24 patients. No connection was found between the development of hypopituitarism and any of the clinical parameters assessed on-admission or at ICU. Significant correlations were found between early endocrine dysfunctions and surgical intervention (OR: 4.64) and the diagnosis of subdural hematoma (OR: 12). In our population, after road traffic accidents, the development of late-onset hypopituitarism was less prevalent (OR: 0.22). CONCLUSIONS Since our results do not indicate any reliable predictive parameter for the development of endocrine dysfunction in a cohort of patients with severe traumatic brain injury, regular endocrine screening of this specific patient population seems obligatory.

Actions (login required)

Edit Item